3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
34
Leukemia
15
Gastrointestinal Stromal Tumors
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Leukemia, Myeloid, Chronic-Phase
7
Philadelphia Chromosome
4
Leukemia, Myeloid
4
Bone Marrow Diseases
4
Neoplasms
3
Myeloproliferative Disorders
3
Hematologic Diseases
3
Melanoma
2
Hematologic Neoplasms
2
Bronchiolitis Obliterans Syndrome
2
Blast Crisis
2
Synovitis, Pigmented Villonodular
1
Recurrence
1
Piebaldism
1
Peritoneal Neoplasms
1
Ovarian Neoplasms
1
Neurofibromatoses
1
Neurofibroma, Plexiform
1
Neurofibroma
1
Neoplastic Processes
1
Neoplasms by Histologic Type
1
Neoplasm Metastasis
1
Mastocytosis, Systemic
1
Leukemia, Myeloid, Accelerated Phase
1
Hypereosinophilic Syndrome
1
Glioma
1
Interventions
Paclitaxel
19
pembrolizumab
16
Carboplatin
12
Bevacizumab
8
lenvatinib
6
rucaparib
5
Nivolumab
5
Megestrol Acetate
5
Radiation
4
Indocyanine Green
4
Gemcitabine
4
Cisplatin
4
tisotumab vedotin
3
temsirolimus
3
Sirolimus
3
Sentinel Lymph Node Biopsy
3
Magnetic Resonance Spectroscopy
3
Doxorubicin
3
olaparib
2
niraparib
2
ixabepilone
2
iso-sulfan blue
2
irosustat
2
epacadostat
2
durvalumab
2
copanlisib
2
Trastuzumab
2
Taxes
2
Specimen Handling
2
Radiotherapy, Intensity-Modulated
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Endometrial Neoplasms
×
nilotinib
×
Clear all
No trials found.